Eu Ivdd Eu Ivd General On The Market 🇸🇬 Singapore

RapidKey COVID-19 Antigen Self Test (7)

Vela Operations Singapore Pte. Ltd. · 🇸🇬 Singapore
Devices (same UDI-DI)
1
Certificates
1
Countries
0
Notified Bodies
1

Basic Information

Primary DI
08885013959543
Basic UDI-DI Code
B-08885013959543
Reference
301114
Device Types
Single use
Regulation
Eu Ivdd
Classification
Eu Ivd General
Status
On The Market

Additional Description

The RapidKey COVID-19 Antigen Self Test for the novel coronavirus (SARS-CoV2, which causes COVID-19) is a diagnostic test. The test is to be used as an aid in the rapid diagnosis of infection with SARS-CoV-2. The test is used for the direct and qualitative detection of viral protein (the antigen: N protein) of SARS-CoV-2 in nasal mucus. The rapid test uses highly sensitive antibodies to measure the N protein. With this self-testing test, you can find out if you are infected with the virus caused COVID-19. To be used as a self-test from the age of 16. For children under the age of 16, a legal guardian will perform the test or the test will be done under their supervision.

CND Nomenclature Codes

Code Description
W0105040619 CORONAVIRUS [obsolete from 2025-01-01]

Certificates

Type Number
IVDD Annex IV (excluding sections 4, 6) HL 2074998-1

Similar Devices

Other on-the-market devices with the same classification (Eu Ivd General) and regulation (EU IVDD).

View all